search icon

Price related data not available

Kailera Therapeutics Analyst Forecast

Price related data not available

Kailera Therapeutics Stock Returns

Data is not properly formatted.

Kailera Therapeutics Ratios

Kailera Therapeutics Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

KLRA
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Kailera Therapeutics Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

KLRA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Kailera Therapeutics share price today?

Kailera Therapeutics (KLRA) share price today is $26

Can Indians buy Kailera Therapeutics shares?

Yes, Indians can buy shares of Kailera Therapeutics (KLRA) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KLRA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Kailera Therapeutics be purchased?

Yes, you can purchase fractional shares of Kailera Therapeutics (KLRA) via the Vested app. You can start investing in Kailera Therapeutics (KLRA) with a minimum investment of $1.

How to invest in Kailera Therapeutics shares from India?

You can invest in shares of Kailera Therapeutics (KLRA) via Vested in three simple steps:

  • Click on Sign Up or Invest in KLRA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Kailera Therapeutics shares
What is Kailera Therapeutics 52-week high and low stock price?

The 52-week high price of Kailera Therapeutics (KLRA) is $. The 52-week low price of Kailera Therapeutics (KLRA) is $.

What is Kailera Therapeutics price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Kailera Therapeutics (KLRA) is

What is Kailera Therapeutics price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Kailera Therapeutics (KLRA) is 0.00

What is Kailera Therapeutics dividend yield?

The dividend yield of Kailera Therapeutics (KLRA) is 0.00%

What is the Market Cap of Kailera Therapeutics?

The market capitalization of Kailera Therapeutics (KLRA) is

What is Kailera Therapeutics's stock symbol?

The stock symbol (or ticker) of Kailera Therapeutics is KLRA

How Can Investors Use Kailera Therapeutics Share Price Data for Long-Term Investment Decisions?

Consider the share price of Kailera Therapeutics as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Kailera Therapeutics has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Kailera Therapeutics shares for Indian investors?

When investing in Kailera Therapeutics shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Kailera Therapeutics stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Kailera Therapeutics share price with other stocks in the same sector?

Rather than merely checking the share price of Kailera Therapeutics and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Kailera Therapeutics stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top